Results 181 to 190 of about 226,558 (238)

Cervical cerclage versus cervical pessary with or without vaginal progesterone for preterm birth prevention in twin pregnancies and a short cervix: A two-by-two factorial randomised clinical trial. [PDF]

PLoS Med
He YTN, Pham HNH, Nguyen TC, Bui TQ, Vuong NT, Nguyen DTN, Le TV, Li W, Le CH, Ho TM, Mol BW, Dang VQ, Vuong LN.   +12 more
europepmc   +1 more source

Live births after vaginal progesterone Cyclogest suppository versus Crinone gel for luteal phase support following cleavage and blastocyst cryopreserved embryo transfer (CET); a retrospective comparative study. [PDF]

JBRA Assist Reprod
Alharbi D, Nadreen M, Albaiji A, Al-Jaroudi D.   +3 more
europepmc   +1 more source

Comparing cervical cerclage, pessary and vaginal progesterone for prevention of preterm birth in women with a short cervix (SuPPoRT): A multicentre randomised controlled trial. [PDF]

PLoS Med
Hezelgrave NL, Suff N, Seed P, Robinson V, Carter J, Watson H, Ridout A, David AL, Pereira S, Hoveyda F, Girling J, Vinayakarao L, Tribe RM, Shennan AH, SuPPoRT Collaborating Team.   +14 more
europepmc   +1 more source

Effects of vaginal progesterone and placebo on preterm birth and antenatal outcomes in women with singleton pregnancies and short cervix on ultrasound: a meta-analysis. [PDF]

Front Med (Lausanne)
Peng L, Gao Y, Yuan C, Kuang H.
europepmc   +1 more source

Rectal versus vaginal progesterone administration for luteal phase support in the hormone replacement therapy frozen embryo transfer (HRT-FET) cycle: protocol for a non-inferiority randomised controlled trial. [PDF]

BMJ Open
Alsbjerg B, Humaidan P.
europepmc   +1 more source

Vaginal Progesterone for Pregnancy Prolongation After Arrested Preterm Labor: A Randomized Clinical Trial.

JAMA Netw Open
Nachum Z, Ganor Paz Y, Massalha M, Wated M, Harel N, Yefet E.   +5 more
europepmc   +1 more source

The combination of dydrogesterone and micronized vaginal progesterone can render serum progesterone level measurements on the day of embryo transfer and rescue attempts unnecessary in an HRT FET cycle. [PDF]

J Assist Reprod Genet
Lawrenz B, Kalafat E, Ata B, Del Gallego R, Melado L, Elkhatib I, Fatemi H.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vaginal Progesterone and the Vaginal First-Pass Effect

Climacteric, 2018
Vaginal progesterone is an effective alternative to systemic administration by oral or intramuscular use. The first-pass effect is reviewed, as are the most common uses for this route of delivery. This includes use in hormone replacement therapy, luteal support particularly in assisted reproduction, and avoidance of side-effects of oral progestins and ...
M P Warren
exaly   +3 more sources

Addition of Intramuscular Progesterone to Vaginal Progesterone in Hormone Replacement Therapy in Vitrified–Warmed Blastocyst Transfer Cycles

Reproductive BioMedicine Online, 2020
Research question: Does intramuscular progesterone supplementation ensure ongoing pregnancy rates (OPR) comparable with vaginal progesterone only in hormone replacement therapy cycles for vitrified-warmed embryo transfer; and is there a window of serum ...
Peter Humaidan, Sezcan Mumusoglu, Hakan Yaralı   +2 more
exaly   +2 more sources

Vaginal Progesterone for Contraception

Fertility and Sterility, 1978
Silastic vaginal rings impregnated with progesterone (P) or progesterone and estradiol (E) were used in nine women for thirty 21-day cycles to study the effect on ovarian function. The average daily rates of release of P and E from the rings were 2.2 mg/day and 220 microgram/day, respectively.
A, Victor, T M, Jackanicz, E D, Johansson   +2 more
openaire   +2 more sources